Logo

Manohar Furtado

Aug 15, 2017

LexaGene has appointed Manohar Furtado to its board of directors. With over 30 years of experience in the life science industry, Furtado has worked in discovery research, clinical diagnostic testing, product development and commercialization, M&A activity, fundraising, and strategy. He currently serves as president and founder of Biology for Global Good and CSO and chief regulatory officer at Apton Biosystems. Prior to Biology for Global Good, he served as VP of R&D at Applied Biosystems.

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.